ICAP
  • Date: October 6-10, 2024
  • Location: Lima, Peru, and online

At the 5th HIV Research for Prevention Conference in Lima, Peru, ICAP experts will feature research on HIV prevention from studies conducted around the world. Please see below for a summary of ICAP’s presence at HIVR4P 2024.

Country

Title/Topic

Authors

Disposition

ICAP-LED

multi-country

Assessing oral pre-exposure prophylaxis (PrEP) awareness and willingness to use among sexually active adults in five African countries: results from the population-based HIV impact assessment.

Mansoor Farahani, Shannon M. Farley, Herbert Longwe, Lyson Tenthani, Limpho Maile, Owen Mugurungi, David Hoos, Wafaa M. El-Sadr

e-poster

Tanzania

Utilization of Community Safe Spaces for Improving HIV PrEP Uptake Among Adolescent Girls and Young Women in Nyamagana Council, Tanzania: 2022-2023

Agness Mongella, Julie Franks, Teckla Odero, Flavia Rugemarila, Jane Kitalile, Allen Katale, Neema Gwido, Magreth Kagashe, Haruka Maruyama, Omari Msumi

poster

Cameroon

Strides made by ICAP Cameroon in HIV case finding in the Northern Regions of Cameroon from October 2019 to September 2023

G.E.F. Tayong1,2, G.L. Ekali3, P.R. Enokbonong4, C.S. Tchokonte1, S.M. Azekang1

e-poster

Comparing Trajectories of Change in PrEP Readiness Across an Intervention Trial to Increase Uptake Among Young South African Women: A Markov Modeling Approach

Elise Mara

poster

NON-ICAP LED

Navigating ethical considerations in HIV prevention research: insights and challenges

E. Mwore1, J. Zech2, J. Walimbwa1, S. Tabbu3

poster

Exploring HIV prevention products and acceptability among men who have sex with men aged 18-25 years in Kenya

E. Mwore1, J. Walimbwa1, S. Tabbu2, J. Zech3

poster

Enhancing engagement of men who have sex with men in HIV prevention research studies in Kenya: strategies and lessons learned

E. Mwore1, J. Walimbwa1, S. Tabbu2, J. Zech3

poster

Scaling pre-exposure prophylaxis (PrEP) through Global Fund grants: a comparative analysis of prioritized strategies and innovations in Kenya, Mozambique, Nigeria, Uganda, and Zambia

D. Resar1, A. Olowu2, P. Haimbe3, T. Mwamba3, B. Longwe-Ngandwe3, M. Silondwa3, M. Chilembo3, O. Wiwa2, F. Lufadeju2, J. Kama2, N. Otubu2, O. Abudiore2, O. Sowale2, O. Eberendu2, E. Pimentel de Gusmao4, M. Rodolph5, M. Prochazka5, C. Obermeyer6, R. Borain7, S. Jenkins1

poster

PrEP use and association with recent HIV infection among sexual contacts of Rwandan people newly diagnosed with HIV

J. McLean1, E. Poirot2J.C. Irabona3C. Kamanzi3V. Mugisha3, E. Remera4, E. Kayirangwa5, T. Oluoch5, S. Malamba5, D. Miller6, A. Suthar6, K. Lee6, G. Rwibasira4, S. Saito7,2

e-poster

PrEP uptake and adherence among transgender women: findings from a randomized clinical trial of a multicomponent intervention (HPTN 091)

T. Poteat1, G. Beauchamp2, M.A. Marzinke3, K. Gomez-Feliciano4, B. Akingbade4, J. Beck5, I. Bell2, V. Cummings3, L. Emel2, J. Franks6, E.M. Jalil7, J.E. Lake8, A. Liu9, J. Lucas4, K.H. Mayer10, A.E. Radix11, J. Rooney12, H. Spiegel13, D.L. Watson14, S. Zangeneh15, S.L. Reisner16, HPTN 091 Study Team

oral abstract

Related Items